He C, Chen J, Ao S, Lu C
Department of Neurobiology, Second Military Medical University, Shanghai, China.
Neurosci Res. 1995 Nov;23(4):327-33. doi: 10.1016/0168-0102(95)00958-V.
Ciliary neurotrophic factor (CNTF) is a trophic protein that promotes survival and/or differentiation of a variety of neuronal cell types including sensory, sympathetic, and motor neurons. CNTF, leukemia inhibitory factor (LIF), interleukin-6 (IL-6) and oncostatin M (OSM) share a predicted common helical framework and partially identical receptor components. In this study, we present the preparation and structure--functional analysis of recombinant human CNTF. The human CNTF gene was expressed under the control of the PL promoter in Escherichia coli, and the mutants were constructed by insertion, deletion and site-directed mutagenesis. The recombinant proteins were purified from bacteria via DEAE A-50 and Sephacryl S-200 chromatography, and their survival promoting activities were determined using cultures of embryonic chick dorsal root ganglion (DRG) neurons. Insertion at position 23 with APGL, or at position 79 with PRGA, or substitution of 162L163Q for PIDG resulted in proteins with no neurotrophic activity. However, insertion at position 186 with PRGI did not alter human CNTF activity. Deletion of the carboxy-terminal amino acid 186-200 did not reduce the biological activity, but elimination of the amino acid 162-186 abolished the activity. The mutant substituting of 17 Cys for Ser was found to display a biological activity equivalent to that of the wild type. Our data provided experimental confirmation for the structural prediction of CNTF.
睫状神经营养因子(CNTF)是一种营养蛋白,可促进多种神经元细胞类型(包括感觉神经元、交感神经元和运动神经元)的存活和/或分化。CNTF、白血病抑制因子(LIF)、白细胞介素-6(IL-6)和制瘤素M(OSM)具有预测的共同螺旋结构框架和部分相同的受体成分。在本研究中,我们展示了重组人CNTF的制备及其结构-功能分析。人CNTF基因在大肠杆菌中受PL启动子控制表达,通过插入、缺失和定点诱变构建突变体。重组蛋白通过DEAE A-50和Sephacryl S-200色谱从细菌中纯化出来,并使用鸡胚背根神经节(DRG)神经元培养物测定其促存活活性。在第23位插入APGL、第79位插入PRGA或用162L163Q取代PIDG会导致蛋白质无神经营养活性。然而,在第186位插入PRGI不会改变人CNTF活性。缺失羧基末端氨基酸186 - 200不会降低生物活性,但去除氨基酸162 - 186会消除活性。发现用丝氨酸取代第17位半胱氨酸的突变体具有与野生型相当的生物活性。我们的数据为CNTF的结构预测提供了实验证实。